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NOCARDIAL INFECTIONS: REPORT OF 22 CASES
Maria Bernadete F. CHEDID(1), Marcio F. CHEDID(2), Nelson S. PORTO(3), Cecília B. SEVERO(4) & Luiz Carlos SEVERO(4,5)
SUMMARY
Twenty-two cases of nocardial infections were diagnosed in our city between 1977- 1998. All patients whose clinical specimens
showed Nocardia spp. at Gram stain, which were further confirmed by culture, were selected to be included in the study. Data from
patients who were cured were compared with those from patients who died by statistical tests using EPIINFO version 6.04
software. Six isolates were identified as Nocardia asteroides complex, one as Nocardia asteroides sensu stricto and other as
Nocardia brasiliensis. We had 17 cases of lung nocardiosis, being one out of them also a systemic disease. Other four cases of
systemic nocardiosis were diagnosed: nocardial brain abscesses (one); nocardiosis of the jejunum (one); multiple cutaneous
abscesses (one); and a case of infective nocardial endocarditis of prosthetic aortic valve. One patient had a mycetoma by N.
brasiliensis. Fifteen (68.2%) out of 22 patients were immunosuppressed, being most (93.3%) by high-doses corticotherapy. Mortality
by nocardial infection was 41%; mortality of systemic nocardiosis was 60%. Nocardiosis has a bad prognosis in immunosuppressed
patients and also in non-immunosuppressed patients if the diagnosis is delayed. We propose that the delay in diagnosis should be
examined in larger series to document its influence in the prognosis of the disease.
KEYWORDS: Nocardia species; Nocardial infection; Pulmonary nocardiosis; Systemic nocardiosis; CNS nocardiosis; Cutaneous
nocardiosis; Small bowel nocardiosis; Nocardial endocarditis.
INTRODUCTION
Nocardiosis is a worldwide disease known as an infection that
affects predominantly patients with immunodepressive diseases3. The
microorganism was first described by Nocard in 1888 as a fungus and
was further classified as an aerobic bacteria that belongs to the genus
Nocardia, order Actinomycetales. They are saprophytic organisms
ubiquitous in nature, commonly isolated from soil, typically
filamentous, aerobic branching gram-positive bacteria whose bacterial
filaments fragment to coccobacillary forms.
Species more associated with infections in humans are N. asteroides
(sensu stricto), N. brasiliensis, N. farcinica and N. nova; less commonly
N. otitidiscaviarum and N. pseudobrasiliensis; and rarely associated,
or whose prevalence is not yet established: N. abscessus, N. brevicatena
complex, N. africana, N. paucivorans, N. asteroides type IV, N. carnea,
N. transvalensis and N. veterana28.
In this study, we present clinical and microbiological characteristics;
treatment and outcome of 22 cases of nocardial infection diagnosed in
our laboratory for a period of twenty-two years.
MATERIALS AND METHODS
We retrospectively revised through database analysis all cases of
nocardial infections diagnosed between January 1977 and December
1998 in our mycology laboratory that serves two reference hospitals
(respectively of 735 and 1,100 beds) in an urban center with 1.4 million
inhabitants in Southern Brazil.
Clinical data were collected at the time of laboratorial diagnosis
and most patients had follow-up for at least one year. Eventually we
reviewed the laboratory data and the hospital files again in order to
collect all necessary data.
Clinical specimens for laboratory examination were pus, sputum,
bronchial secretions, pleural effusions drawn by thoracentesis;
percutaneous needle aspirates of the lung, or surgically removed tissue.
Pus and grains were mounted in a drop of 10% potassium hydroxide;
pus and smashed grains, sputum or sediment of bronchoalveolar lavage
or lung aspirates were smeared and stained by Gram’s technique. Cut
sections of tissues were stained by H & E and Brown-Brenn techniques.
If either branching, Gram-positive thin filaments compatible with
Nocardia spp. were seen at Gram stain, it was performed the modified
Kinyoun stain and the Ziehl-Nielsen stain to the acid-fastness
examination. Further the clinical specimen was cultured in Sabouraud’s
dextrose agar and incubated aerobically at room temperature and at
37 ºC for one week. If colonies suggestive of Nocardia spp. grew in at
least one culture media, extended cultures were performed in
Lowenstein-Jensen media. Genus identification of Nocardia spp. was
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based upon appearance at either Gram stain or modified Kinyoun stain;
and colony morphology: isolates had macroscopic aerial bacterial
filaments and microscopic long, thin, branched filaments. Each
microorganism was subcultured on plates containing casein, gelatin,
tyrosine, xanthine and urea28. Some isolates were sent to CDC at the
time of diagnosis to confirm or to define the species of Nocardia, but
attempts were not made at our laboratory to distinguish members of
N. asteroides complex until 1994.
We classified our cases as others3 as:
1) Pulmonary nocardiosis when the lung was involved;
2) Extrapulmonary nocardiosis when other organs were involved
without the concomitant involvement of the lung, but we distinguish
CNS nocardiosis when the brain was involved, requiring to it the
isolation of Nocardia sp. from brain lesion;
3) Mycetoma was classified as a primary skin infection being a
local, chronic, slowly progressive destructive infection of the skin,
subcutaneous tissues, fascia, bone and muscle, containing suppurative
granulomas and multiple sinus tracts that extrude grains;
4) Systemic nocardiosis: when the infection has disseminated to
the blood or to at least one more non-contiguous organ. Either the
finding of a brain lesion proved of nocardial origin; the isolation of
Nocardia spp. from a patient with arthritis; the finding of multiple
nocardial cutaneous lesions; or the isolation of Nocardia spp. from
gastrointestinal lesions were all classified as systemic nocardiosis -
since it is presumed that the infection has originated from a primary
foci, from where it has disseminated giving infectious “metastatic”
lesions to such organs. The isolation of Nocardia species from
subphrenic and subhepatic abscess in a patient with adjacent pleural
nocardiosis was considered localized nocardiosis, since the
dissemination of the disease should have occurred through local
lymphatic channels.
Underlying chronic disease was defined as presence of heart disease,
liver disease, renal disease, lung disease or diabetes mellitus.
Immunosuppression was defined as presence of HIV infection, previous
splenectomy, hematological malignancy, autoimmune disorder,
transplant recipients and receipt of cancer chemotherapy within four
weeks35 or prednisolone use of at least 10 mg/day (or equivalent doses
of other steroids) in the last three months.
Time in diagnosis was defined as the mean duration of the disease
from the onset of the symptoms to the time of the diagnosis and
prescription of appropriated antibiotics against Nocardia spp. The
diagnosis was defined as “ante mortem” when the patient survived
seven days or less after the prescription of appropriated antibiotics for
nocardial infection.
Data were entered and analyzed using EPIINFO version 6.04D
software. Data from patients with nocardiosis who were cured were
compared with those from patients who died. Differences between
frequencies of categorical variables were determined using the chi-
squared test or Fisher exact test. Time to diagnosis between the group
of patients who died and the group which survived was compared using
the Mann-Whitney test. Statistical comparisons were performed at a
5% level of significance for a 2-tailed test.
RESULTS
Between 1977 and 1998 were diagnosed 22 cases of nocardial
infections (see Tables 1 and 2), being 10 females and 14 males with a
mean age of 45.5 years (range, 21-72). They are numbered consecutively
since the first two Brazilian patients (1 and 2) were diagnosed25.
Etiological diagnosis: Six isolates were identified in our laboratory
as Nocardia asteroides complex (patients 1, 2, 4, 5, 7, 12), one isolate
as Nocardia asteroides sensu stricto type I (patient 22) and one isolate
as Nocardia brasiliensis (patient 6) on basis of their non-degradation
of casein, tyrosine, xanthine, hypoxanthine and adenine, and production
of urease28. Some cases were confirmed by the CDC of Atlanta at the
time of diagnosis: case 1 (094407/77 CDC), case 4 (3882083550/82
CDC), case 6 (3888015409/88 CDC) and case 7 (041849/84 CDC).
We did not provide species identification for 14 isolates and they are
here described as Nocardia spp.
Clinical and radiological presentation: Seventeen cases of lung
nocardiosis were diagnosed and the disease was restricted to lung in
sixteen of these cases, while in one case (patient 8) it was disseminated
(Table 1). We had five cases of systemic nocardiosis (Table 2): one
case of nocardial skin abscesses with concomitant arthritis; one case
of CNS nocardiosis; one case of small bowel nocardiosis; one case
of endocarditis of prosthetic aortic valve and one case of lung
nocardiosis with Nocardia spp. isolated both from the lung and from
an axillary abscess (patient 8, Table 1). And finally we had one case
of mycetoma by Nocardia brasiliensis. Data of all patients are
summarized in Tables 1 and 2, except the patient with mycetoma,
who is described separately.
Lung nocardiosis: Our seventeen cases of lung nocardiosis are
summarized in Table 1, where we can see that five (29.4%) patients
had no immunosuppression, being one patient (number 8) previously
healthy. The other 12 (70.6%) patients had immunosuppression.
All but one of the seventeen patients with lung nocardiosis initially
complained of productive cough. The most common radiological
presentation of lung nocardiosis was consolidation (Fig. 1) which
occurred in 10 patients (58.8%). Lung cavities (Fig. 2 and 3) were
found in nine patients (52.9%). Pleural fluid and pulmonary nodules
(Fig. 4) were found respectively in five patients (29.4%). The diagnosis
was done in seven (41.2%) patients by percutaneous needle aspiration
and in four patients only in the sputum; while in other two patients it
could be only done by open lung biopsy.
Ten patients were treated with TMP-SMX while five took
sulfadiazine and two patients used both drugs, sequentially, due to a
relapse. In only five cases either sulfadiazine of TMP-SMX were used
in combination with beta-lactams (oxacillin, ampicillin), minocycline,
cycloserin or amikacin. Seven out of 17 patients (41.2%) with lung
nocardiosis were cured, while 10 died (58.8%). Among these 10 patients
who died, three deaths (patient 2, 10 and 12) were not directly attributed
to nocardiosis: in the former two patients, the cause of death was
attributed to brain tumor of unknown etiology; while in patient 12,
CHEDID, M.B.F.; CHEDID, M.F.; PORTO, N.S.; SEVERO, C.B. & SEVERO, L.C. - Nocardial infections: report of 22 cases. Rev. Inst. Med. trop. S. Paulo, 49(4):239-246, 2007.
241
Table 2
Systemic nocardiosis in Porto Alegre (Brazil) 1977-1998 §
Case Age/Sex Primary Secondary Etiology Underlying diseases or associated Treatment Evolution
number site site conditions of immunosuppression
14* 42 / M NI Skin abscesses, N. spp. Multiple sclerosis, DPOC, TMP-SMX one year Cure
septic arthritis Diabetes, Corticotherapy
17* 60 / M NI Brain N. spp. Larynx cancer. Non-Hodgkin TMP-SMX/13 days Death
lymphoma
Chemotherapy, Radiotherapy,
Corticotherapy
18* 44 / F NI Jejunum N. spp. Liver transplant, Chemotherapy, Imipenem plus Death
Corticotherapy Vancomycin/10 days
20* 40 / M NI Blood N. spp. No Sulfadiazine plus Cure
aortic prosthesis amikacin six weeks
followed by
TMP-SMX/6 months
a) * Systemic nocardiosis by isolation of Nocardia spp. in other organs or other skin regions, or in the blood. b) § Patient 8 is the fifth case of  systemic nocardiosis and
he is included as lung nocardiosis in Table I. c) NI - Not identified.
Table 1
Nocardial lung infections in 17 patients in Porto Alegre (Brazil) 1977-1998
Case Age/Sex Primary Secondary Etiology Underlying diseases or associated Evolution
number site site conditions of immunosuppression
1 39 / M Lung - N. asteroides COPD Cure
2 46 / F Lung - N. asteroides Brain cancer, COPD, Corticotherapy Death #
3 49 / F Lung N. spp. SLE, Chemotherapy, Corticotherapy Death
4 30 / M Lung Pleura, N. asteroides Kidney transplant, Chemotherapy, Corticotherapy Cure
abdomen
5 21 / F Lung Pleura N. asteroides Kidney transplant, Chemotherapy, Corticotherapy, Cure
7 56 / M Lung - N. asteroides Hepatitis, COPD, diabetes, Corticotherapy Death
8* 57 / F Lung Axillary node N. spp. No Death
9 28 / F Lung - N. spp. Hodgkin´s Lymphoma, Chemotherapy, Radiotherapy, Death
Corticotherapy
10 34 / F Lung  Brain? NB N. spp. Breast cancer, Radiotherapy, Corticotherapy, Death #
11 46 / F Lung - N. spp. Breast cancer, diabetes, Polymyositis, Chemotherapy, Cure
Radiotherapy, Corticotherapy
12 71 / M Lung - N. asteroides AIDS, COPD Death #
13 45 / M Lung - N. spp. Lung cancer, Radiotherapy Cure
(Pleura)
15 25 / M Lung - N. spp. Polymyositis, Corticotherapy Cure
16 46 / M Lung Brain? NB N. spp. COPD Death
19 57 / M Lung - N. spp. Liver transplant, Chemotherapy, Corticotherapy Death
21 55 / F Lung - N. spp. Chronic bronchitis, lung fibrosis lesions after TB Death
22 50 / F Lung - N. asteroides Asthma, Corticotherapy Cure
Sensu stricto
type I
a) Patient number 6 is not included in any table because he had a skin infection only; he had a mycetoma by N. brasiliensis. b) Patient number 8 is the fifth case of
systemic nocardiosis. c) *Proven case of systemic nocardiosis by isolation of Nocardia spp. in other organs or other skin regions, or in the blood. d) NI - Not identified.
e) NB: No Biopsy done.  f) - No secondary foci of infection. g) # Death not attributed to nocardiosis.
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Fig. 6 - Brain CT of patient 17 showing another ring-shaped area of heterogeneous density
in the left frontal lobe.
Fig. 3 - Chest X-Ray of patient 7 showing a nodule and a huge cavity with thick walls in
SRL.
Fig. 2 -Chest X-Ray of patient 2 showing multiple pulmonary nodules in both lungs, being
one at right excavated with thick walls; also we can see consolidations in the SRL; the biggest
nodule is excavated (at left lung), with retained secretions and liquid level.
Fig. 1 - Chest X-Ray of patient 1 showing consolidations in left lung with many cavitations
and a foci of consolidation in IRL.The metallic circle is to guide the percutaneous needle
aspiration maneuver.
Fig. 4 - Chest X-Ray of patient 16 showing pulmonary nodules.
Fig. 5 - Brain CT of patient 17 showing an area of low density in the frontal lobe at right,
ring-shaped, compressing both the head of caudate nucleus and the anterior horn of lateral
ventricle.
who had advanced AIDS with multiple infections, the pulmonary
nocardiosis was considered just a contributing cause of death.
CNS nocardiosis: Patient number 17 was a 60 year-old alcoholic
man who underwent radiotherapy to a larynx cancer seven years ago;
he was on chemotherapy due to a non-Hodgkin lymphoma of small
bowel when he was admitted with fever, headache and drowsiness. No
lung abnormality was noticed either at Chest X-Ray or at
fiberbronchoscopy. Brain CT showed two masses in both frontal lobes
(Fig. 5 and Fig. 6) and a craniotomy was performed for drainage of
these two abscesses, in which pus Nocardia spp. was diagnosed. He
received dexamethasone 16 mg/day and IV TMP/SMX 2g q6h plus
amikacin and ceftazidime but died after 23 days. Patients 10 and 16
(Fig. 4) had both pulmonary nocardiosis and associated brain nodules.
As we could not obtain brain tissue for microbiological analysis we
could not classify both cases as CNS nocardiosis.
Systemic nocardiosis: We had five cases of systemic nocardiosis:
Nocardia spp. was isolated in patients 14, 17 and 18 respectively from
skin, brain and jejunum which were the secondary organs of nocardial
infection; Nocardia spp. was also isolated from an axillary lymph node
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of a patient with lung nocardiosis (patient 8); and finally it was isolated
from the blood in patient 20 (see Table 2) who had infective endocarditis
of the aortic valve prosthesis. In all systemic nocardiosis patients we
could not identify the primary organ affected except in patient 8 (see
Table 1); in this latter patient, the lung was the primary organ affected
by Nocardia spp. from where the infection disseminated, being
Nocardia spp. isolated from an axillary lymph node.
Patient number 14 was admitted with multiple cutaneous abscesses
(in the groin, in upper back, in the buttock, in the neck) and nodule in
the left forearm; swelling and pain in the right knee and both left and
right elbow – reason why he was classified as having systemic
nocardiosis.
Patient 18 was on prednisone 20 mg/day and cyclosporine 450 mg/
day for eight months after orthotopic liver transplantation, when she
was admitted with abdominal pain and fever. She underwent enterectomy
due to a lesion of transverse colon which was not cancer and it was
diagnosed as “colitis”. As she had leukopenia and peritonitis some days
later, she underwent a laparotomy and a fistula between ileum and colon
was seen. A proximal resection of jejunum and ileum was performed
and Gram and culture of surgically removed tissue revealed Nocardia
spp. She was treated with IV imipenem 500 mg q6h plus vancomycin
500 mg q6h but had to undergo to a new laparotomy after five days due
to another abdominal abscess and died after six days.
Patient 20 was a 40 year-old farmer on anticoagulants due to
prosthesis of aortic valve and a tricuspid valvuloplasty eight years
before. He was admitted with axillary temperature of 38.2 ºC, chills
and myalgias. Transthoracic echocardiogram showed aortic
regurgitation and vegetations on the prosthetic valve with paravalvar
leak with minimal aortic insufficiency. Blood samples for culture were
drawn. Due to the hypothesis of infective endocarditis he was prescribed
IV gentamycin plus IV penicillin G but he remained with fever. As
two blood samples drawn with an interval of 14 hours grew Nocardia
spp. sulfadiazine was added and the patient improved. Fifteen days
later he presented fever again and a suppurative phlebitis of the right
arm with bacteremia was diagnosed. Then a new blood culture drawn
grew E. coli resistant to gentamycin, which was replaced by amikacin;
the IV catheter was removed and the patient had clinical improvement.
After six weeks the patient was discharged on PO TMP-SMX 160/800
mg q12h for six months. Transthoracic echocardiogram after 12 months
showed no more vegetation in aortic prosthesis, and the patient remained
well until 2004, when new transthoracic ecochardiogram showed only
minimal mitral valve regurgitation, along with hypo contractile left
ventricle.
Mycetoma: Patient 6 had a mycetoma caused by N. brasiliensis
and was discharged from hospital on sulfadiazine. He came back four
years later with a relapse of mycetoma lesions, telling that stopped
taking sulfadiazine after 3-4 months of treatment, as soon the foot
lesions healed. He then received TMP-SMX for at least six months but
did not come back.
Immunosuppression, treatment and mortality: Seven patients
(31.8%) of our series (cases 1, 6, 8, 13, 16, 20 and 21) had no
immunosuppression that could contribute to the infection by Nocardia
spp. (See Tables 1 and 2). Three out of them died (42.8%).
Immunosuppressive diseases were found in fifteen patients (68.2%):
one patient (6.6%) suffered from AIDS; two patients had hematological
cancer (13.3%); two (13.3%) had autoimmune disorder; four patients
(26.6%) were transplant recipients; in the remaining six patients (40%)
immunosuppression was caused by high-doses corticotherapy due to
solid cancer (three patients), asthma (one patient) or multiple sclerosis
(one patient).
Corticotherapy was the main immunosuppressive condition being
used in 14 out of 15 immunosuppressed patients (93.3%); 10 (71.4%)
out of 14 patients on steroids were using either cytostatic drugs,
radiotherapy or both. Seven patients (50%) were taking corticosteroids
in a doses greater than prednisolone 10 mg/day (median prednisolone
doses = 30 mg/day) for a period between four months and five years.
In the other seven patients (who were taking steroids for less than
three months) the median daily prednisolone dose was greater than 50
mg/day. Nine out of fifteen immunosuppressed patients died, but in
only six cases (40%) the death was attributed directly to nocardiosis.
Three patients (13.6%) had diabetes, being in all cases associated
with the use of high-dose steroids. Chronic obstructive pulmonary
disease (COPD) occurred in six patients (27.3%) but mostly (in four
patients) it was associated either with severe immunodepressive
diseases or to the use of high-doses corticosteroids or both (see Tables
1 and 2).
Sulfa derivatives (TMP/SMX or sulfadiazine) either alone or in
combination with other antibiotics were used for the treatment of these
patients except one, who used imipenem plus vancomycin (patient 18).
TMP-SMX was used in 13 (59%) patients and sulfadiazine was used
in four (18.1%) patients. Both drugs were used sequentially in four
(18.1%) patients whose nocardial infection relapsed respectively due
to short course of treatment (patient 6), due to intolerance (patient 10)
or another reasons (patients 11 and 20).
From 22 patients of our series, nine deaths were attributed to
nocardial infection, so mortality by nocardial infection was 41%; while
10 cases obtained cure (45.4%). Time to diagnosis (data not shown)
between the group who died (mean 29.4 days, standard deviation 29.67)
and the group who survived (mean 36 days, SD 32.64) compared by
Mann-Whitney test showed no statistical significant difference between
groups. In six out of nine patients whose death was directly attributed
to nocardiosis the diagnosis of nocardial infection and the prescription
of appropriated antibiotic was ante mortem, i.e., they received
sulfadiazine or TMP-SMX for less than seven days before death (mean
= 6.5 days).
Although the delay in diagnosis in the group of patients with
systemic nocardiosis who died (three patients, 41.3 days, SD 30.61),
and the delay in the group of patients who survived (two patients,
eight days, SD 4.24) suggests the delay in the diagnosis might have
contributed to death in patients with disseminated nocardiosis, it did
not reach a level of statistical significance. Statistical analysis between
patients who died also showed that the patients who took sulfadiazine
did not die more than the group who took TMP-SMX at a 5% level of
significance for a 2-tailed test.
Mortality of nocardial infection in our series was 41%, being 40%
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in the group of immunosuppressed patients (n = 15) and 43% (three
out of seven) in the group of non- immunosuppressed patients - thus
we found no statistical significant difference at a 5% by Person Chi-
Squared test or Fisher exact test regarding immunosuppression between
patients who died compared to the ones who survived.
Seven out of 17 patients with pulmonary nocardiosis died (41.2%).
Systemic nocardiosis had a mortality of 60% (three out of five cases).
DISCUSSION
Nocardial infections in USA are most frequently caused by N.
asteroides sensu stricto type VI, N. brasiliensis, N. farcinica, and N.
otitidiscaviarum28. In Germany the predominant species identified is
N. farcinica (60.3%)29. In Japan 303 cases of nocardiosis were diagnosed
showing that most were caused by N. asteroides complex (72.3%),
being N. farcinica the predominant species (81 strains) followed by N.
asteroides (72 strains) and N. brasiliensis (66 strains)17; while in France
66.7% of isolates were N. asteroides and 23.8% were N. farcinica6. In
Brazil the reported lung infections were caused by N. asteroides
complex25,27. This is the largest series of nocardial infections in Brazil
since we published the first two pulmonary cases25 which are included
in the present series (patients 1 and 2).
In all our cases Gram stain at first was diagnostic of nocardial
organisms confirming to be the most sensitive method to visualize
Nocardiae in clinical specimens28, leading to definitively establish the
diagnosis by a positive culture. As we have performed most of our
diagnostic work up between 1977 and 1998, we have only one isolate
of N. asteroides sensu stricto while the other seven isolates are classified
only as N. asteroides complex.
Nocardia species most commonly infects humans through the
respiratory tract by inhalation, being the lung the main organ affected.
Clinical manifestations of lung and systemic nocardiosis are not specific
and include anorexia, weight loss, productive cough, and oft pleural
pain and often dyspnea3,16,22-24,26,34 as in our series, reason why its
diagnosis is difficult. Lung nocardiosis was diagnosed in most of our
patients (72.3%) in our series, being in 16 patients localized while in
one case it was systemic (patient 8). We had four more cases of systemic
nocardiosis (22.7%) which comprised cutaneous nocardiosis with
arthritis (case 14), CNS nocardiosis (case 17), nocardiosis of small
bowel (case 18) and a case of infective endocarditis of prosthetic aortic
valve (case 20). And finally we had one case of mycetoma which is a
localized skin infection that seldom disseminates, as in our patient.
We found as most common radiographic patterns of lung
nocardiosis as others13 consolidations (11 cases, 64.7%); in nine out of
11 cases the consolidations were already excavated with abscess
formation; pulmonary nodules (five cases, 29.4%) and pleural effusion
(five cases, 29.4%). Nocardiosis is commonly mistaken with bacterial
pneumonia, tuberculosis, histoplasmosis, actinomycoses, lung cancer
or bacterial abscess13.
Nocardia spp. may also cause primary disease in the skin by its
traumatic introduction from soil. This primary skin infection is rare,
often with a subacute course, presenting as cellulitis, lymphocutaneous
disease or mycetoma in the immunocompetent patient; nocardial
mycetomas may be caused by most of nocardial species but more
frequently by N. brasiliensis, as occurred with patient 6 of our series.
Mycetoma usually remains a localized lesion, as in our patient, rarely
disseminating to the lungs and normal skin18.
In immunosuppressed patients nocardiosis is an opportunistic
infection which more often disseminates to the CNS or to the skin,
causing abscesses, nodules or cellulitis3,34 similarly to patient 14 of
our series, who was admitted with multiple cutaneous abscesses and
arthritis. He was classified as systemic nocardiosis: his multiple skin
lesions and concomitant arthritis suggests haematological
dissemination, but we could not identify the initial foci of nocardiosis.
Cutaneous nocardiosis resulting from dissemination may be
indistinguishable of cutaneous primary nocardiosis, so it is
recommended to always search for a pulmonary primary foci34. Both
our patients with nocardial skin infections were cured, despite of being
a systemic disease in patient 14.
Central nervous system nocardiosis occurs in approximately 22%
of nocardiosis series3 and in 25% of all cases of lung nocardiosis,
presumably being secondary to blood dissemination from an
asymptomatic or healed lung infection15. CNS was the second most
common organ involved in two large series of patients with nocardiosis,
reaching an incidence of 43.5%26 and 23%24. The main symptoms and
signs of cerebral nocardiosis include headache, nausea, vomiting and
depressed consciousness and are not different from the symptoms of
other bacterial abscesses15 or metastatic cancer30. In our series we had
only one proved case of brain nocardiosis (patient 17) in whom a
primary site of infection was never identified. Patients 10 and 16 had
both lung nocardiosis and brain nodules at CT but their lesions were
not either biopsed or resected, thus they can not be classified as CNS
nocardiosis23. It is recommended brain CT be performed in every patient
with nocardial infection, since it was noticed in a review of 120 cases
of nocardial brain abscesses that 66% of the patients had a primary
foci, being a subcutaneous/cutaneous foci in 20% and a pulmonary
one in 38% of the cases. It was also reported high mortality to nocardial
brain abscesses in immunosuppressed patients (55%), contrasting with
a mortality of 20% in non-immunocompromised patients21.
Intestinal nocardiosis has been reported very rarely7. Acute
fulminant clinical course with peritonitis may be related to
immunosuppression as occurred with one of our patients. Although
high index of suspicion could reveal colonic or duodenal nocardiosis
by endoscopic examination with biopsy, correct diagnosis may not be
obtained before laparotomy.
Six reports of nocardial infective endocarditis of prosthetic valves
were reported1,8,10-12,33. In four out of them1,8,10,11 blood cultures were positive,
but only three patients survived after treatment: two patients underwent
aortic valve replacement10,11, while the third one8 was cured only on
antibiotic treatment, like our patient. In our patient it was not identified
any other foci of nocardiosis and the infection occurred eight years after
the surgery; he had two positive blood cultures to Nocardia spp. and
transthoracic echocardiogram showed vegetations in the aortic valve
prosthesis; it was fulfilled two major and two minor Duke’s criteria9 being
then a definitive clinical diagnosis of nocardial infective endocarditis,
confirming the finding that it does not always require aortic prosthesis
replacement8; and also suggesting that the use of IV sulfadiazine (six weeks)
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followed by PO TMP-SMX (six months) for the treatment of infective
nocardial endocarditis may be successful in some cases.
We had four (18.2%) organ recipients (two kidney and two liver
recipients) with nocardiosis. The disease occurs mainly during the first
year after transplant secondary to the highest dosis of corticosteroids20,
as occurred in three transplanted patients of our series.
Our kidney transplant recipients both had lung nocardiosis. Patient
4 underwent living donor kidney transplantation and five years later
was admitted due to bronchopneumonia and pleural effusion. He
presented subhepatic and subphrenic abscesses where it was isolated
N. asteroides complex as well as in the pleural effusion, further
confirmed by CDC. Patient 5 had received a cadaveric kidney transplant
being at this time hospitalized in the same ward. This latter patient
was finally discharged after one month without any pulmonary lesion
at Chest X-Ray. One month later she reported respiratory symptoms
and was admitted with pulmonary consolidation and leukopenia. She
had hemoptysis and a cavity appeared in the IRL along with pleural
effusion in which was isolated N. asteroides complex. Both patients
received TMP-SMX, getting cured. We think there may have been
nosocomial transmission of nocardiosis in our hospital- even though
we can not prove it by characterization of both nocardial strains2,5.
To our knowledge, this is the first case of pulmonary and systemic
nocardiosis by N. asteroides complex in HIV-positive patient reported in
our country so far. Despite the fact that the incidence of nocardiosis in
AIDS patients is more than 140 times greater in average than that in general
population14, it is not a common diagnosis in our country where most
HIV-positive patients use prophylaxis with TMP- SMX. Our patient had
CD4 < 150 cells per µL as reported32, not being on TMP/SMX prophylaxis
for Pneumocystis jirovecii pneumonia. Due to the advanced
immunodeficiency and many concomitant infections, in this very patient
nocardiosis was not considered the main cause of death as in other reports32.
The predisposition to nocardiosis in patients with malignant
diseases may be either related to the primary disease or to the use of
cytostatic drugs4. Six out of the 22 cases here presented (27.3%) had
malignant diseases, being two out of them hematological cancer.
Immunodepression is a known risk factor for dying of pulmonary
or systemic nocardiosis26; it was reported that in a group of 1000 patients
with nocardiosis 64.3% were immunodepressed (with a mortality of
42.4%); while in the group of non-immunodepressed patients with
nocardiosis, mortality was 19.8%3. In our series 68.2% of the patients
are immunosuppressed with a mortality of 50%.
Despite the fact that immunosuppressed patients usually have higher
mortality, this finding was not confirmed in our series, since among
the group of six non-immunosuppressed patients mortality was also
high (50%): one patient died with systemic disease (patient 8); other
with lung bilateral nocardiosis with multiple cavitations and symptoms
for less than three weeks (patient 21), both known risk factors for dying
of nocardiosis26; and finally, patient 16 had lung nocardiosis and brain
tumors of unknown aetiology; thus all three had a bad prognosis despite
being non- immunosuppressed, reason why in this small group of six
patients with systemic nocardiosis the mortality was similar between
both groups.
Our patient with multiple nocardial brain abscesses died despite
adequate surgical treatment, according to the high mortality (66%)
reported in such cases21.
Disseminated nocardiosis is often a late-presenting and life
threatening infection, most frequently secondary to hematogenous
spread from a pulmonary infection23. Three out of our five cases of
disseminated nocardiosis died (60%), confirming the high mortality
reported by the literature: patients with systemic nocardiosis have a
mortality rate of 44%3,23; if their infection is bacteremic their mortality
may be 50%19 and if severely immunocompromised it can reach 85%26.
The weakness of our work is that we could not identify the species
of Nocardia in all our 22 cases (diagnosed between 1977-1998),
similarly to other reports9,16,22,30 which did not either identify the species
of Nocardia in a range of 9% to 25% even though some had used
molecular diagnostic methods; and also despite their diagnostic work
up had been done either after 198822,30 or after 199516,28.
The delay in diagnosis and consequently the delay in treatment of
our patients with systemic nocardiosis might have contributed to their
death, although it had no reached a level of statistical significance in
our series. It was previously suggested that the survival might be higher
if the diagnosis was made earlier in the course of the disease26. We
propose that this variable should be examined in a large series of
nocardial infection, adjusting for other variables as immunosuppression
and species of Nocardia, especially in the group of systemic nocardiosis.
We think it is reasonable that advanced disease should have a worse
prognosis; and high mortality might be due either to the predominance
of infections caused by invasive nocardial species resistant to multiple
antimicrobial agents as Nocardia farcinica6,29,31 which was not properly
investigated in our series at the time.
RESUMO
Infecções por Nocardia species: relato de 22 casos
São apresentados 22 casos de infecção por Nocardia species entre
1977 e 1998, apresentando-se seu quadro clínico e evolução. Todos os
pacientes cujos espécimes clínicos mostraram microorganismos
sugestivos de Nocardia spp. à coloração de Gram, confirmados
posteriormente por cultura, foram incluídos no estudo. Os dados dos
pacientes que obtiveram cura foram comparados com aqueles dos
pacientes que foram a óbito pelo programa EPIINFO versão 6.04; nível
de significância menor que 5% foi considerado estatisticamente
significativo. Foram obtidos 22 casos de infecção por Nocardia spp.:
seis isolamentos identificados como Nocardia asteroides complex, um
como Nocardia asteroides sensu stricto e outro como Nocardia
brasiliensis, enquanto os restantes foram identificados como Nocardia
spp. Tivemos 17 casos de nocardiose pulmonar (um com disseminação).
Tivemos outros quatro casos de nocardiose sistêmica: múltiplos
abscessos cerebrais (um); endocardite infecciosa de prótese valvular
aórtica (um); nocardiose de intestino delgado (um); abscessos cutâneos
múltiplos por Nocardia spp (um). Um paciente apresentou micetoma
por Nocardia brasiliensis. Imunossupressão esteve presente em 15
pacientes (68,2%), predominantemente por corticoterapia (93,3%).
Nossa mortalidade foi 41%; a mortalidade dos pacientes com
nocardiose sistêmica foi de 60%. A nocardiose tem pior prognóstico
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em pacientes imunossuprimidos e em pacientes com nocardiose
sistêmica.
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